Skip to Main Content

Paper Details

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
Nat Commun
136
2020
COVID-, IgG, IgM, SARS, SARS-CoV, SARS-CoV-2, anti-nucleocapsid protein IgG, anti-spike IgM, immunoglobulin, immunoglobulin-G, immunoglobulin-M, patient, patients
Author NameAffiliation
Dianna L NgUniversity of California san francisco
Dianna L NgUniversity of California san francisco
Gregory M GoldgofUniversity of California san francisco
Brian R ShyUniversity of California san francisco
Andrew G LevineUniversity of California san francisco
Joanna BalcerekUniversity of California san francisco
Sagar P BapatUniversity of California san francisco
Mars StoneUniversity of California san francisco
Mars StoneVitalant Research Institute
Satish K PillaiVitalant Research Institute
David N NguyenUniversity of California san francisco
Wei GuUniversity of California san francisco
Brian CusterVitalant Research Institute
Jeffrey D WhitmanUniversity of California san francisco
Susan L Stramer
Steve MillerUniversity of California san francisco
Steve Miller
Michael P BuschUniversity of California san francisco
Michael P BuschVitalant Research Institute
Charles Y ChiuUniversity of California san francisco
Charles Y Chiu
Charles Y ChiuUniversity of California san francisco
  • 1 - 22

Datasets

Release 1.2